Göran Ahlgren (Former)
1 – 20 of 35
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)
(
- Contribution to journal › Article
- 2022
-
Mark
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial
(
- Contribution to journal › Article
- 2021
-
Mark
Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study
(
- Contribution to journal › Article
-
Mark
Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
(
- Contribution to journal › Article
- 2020
-
Mark
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
(
- Contribution to journal › Article
- 2019
-
Mark
Population-based, nationwide registration of prostatectomies in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer : Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
(
- Contribution to journal › Article
- 2017
-
Mark
Prostatacancercentrum – navet i framtidens prostatacancersjukvård - En vision som är i linje med det nationella vårdprogrammets riktlinjer : En vision som är i linje med det nationella vårdprogrammets riktlinjer
(
- Contribution to journal › Scientific review
-
Mark
Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease : Semi-ecologic, Nationwide, Population-based Study
(
- Contribution to journal › Article
-
Mark
Podocalyxin-like and rna-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer : A validatory study
(
- Contribution to journal › Article
-
Mark
Long-term functional outcomes after radical cystectomy with ileal bladder substitute : does the definition of continence matter?
(
- Contribution to journal › Article
-
Mark
Prostatacancercentrum - navet i framtidens prostatacancersjukvård
(
- Contribution to journal › Article
-
Mark
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301) : An open-label, phase 3, randomised controlled trial
(
- Contribution to journal › Article
- 2016
-
Mark
Reduction of quality of life in prostate cancer patients : experience among 6200 men in the Nordic countries
(
- Contribution to journal › Article
-
Mark
Value of treatment in clinical trials versus the real world : the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.
(
- Contribution to journal › Scientific review
-
Mark
Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts
(
- Contribution to journal › Article
-
Mark
Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer
(
- Contribution to journal › Article
-
Mark
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
(
- Contribution to journal › Article
- 2014
-
Mark
(18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
(
- Contribution to journal › Article